Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program

Cancer

Volumn 119, Issue 10, 2013, Pages 1838-1844

  Chan, K C Allen ^a   Hung, Emily C W ^a   Woo, John K S ^a   Chan, Paul K S ^a   Leung, Sing Fai ^a   Lai, Franco P T ^a   Cheng, Anita S M ^a   Yeung, Sze Wan ^a   Chan, Yin Wah ^a   Tsui, Teresa K C ^a   Kwok, Jeffrey S S ^a   King, Ann D ^a   Chan, Anthony T C ^a   Van Hasselt, Andrew C ^a   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

early cancer detection; molecular marker; nasopharyngeal carcinoma screening; plasma Epstein Barr virus DNA

Indexed keywords

IMMUNOGLOBULIN A; VIRUS CAPSID ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; DISEASE SURVEILLANCE; DNA DETERMINATION; EARLY DIAGNOSIS; ENDOSCOPY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MALE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY;

ANTIBODIES, VIRAL; ASIA, SOUTHEASTERN; DNA, VIRAL; EARLY DETECTION OF CANCER; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84877578956     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28001     Document Type: Article

References (26)

1. Wei WI, Sham JS,. Nasopharyngeal carcinoma. Lancet. 2005; 365: 2041-2054.
2. Hara W, Loo BW Jr, Goffinet DR, et al. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008; 71: 393-400.
3. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005; 61: 1107-1116.
4. Leung SF, Zee B, Ma BB, et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol. 2006; 24: 5414-5548.
5. Schwarzenbach H, Hoon DS, Pantel K,. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011; 11: 426-437.
6. Leary RJ, Kinde I, Diehl F, et al. Development of personalized tumor biomarkers using massively parallel sequencing [serial online]. Sci Transl Med. 2010; 2: 20ra14.
7. Chan KCA, Jiang P, Zheng YW, et al. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem. 2013; 59: 211-224.
8. Hori SS, Gambhir SS,. Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations [serial online]. Sci Transl Med. 2011; 3: 109ra16.
9. Lee BB, Lee EJ, Jung EH, et al. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res. 2009; 15: 6185-6191.
10. Mutirangura A, Pornthanakasem W, Theamboonlers A, et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res. 1998; 4: 665-669.
11. Lo YMD, Chan LYS, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 1999; 59: 1188-1191.
12. Leung SF, Tam JS, Chan ATC, et al. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody. Clin Chem. 2004; 50: 339-345.
13. Lo YMD, Chan LYS, Chan ATC, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 1999; 59: 5452-5455.
14. Chan ATC, Lo YMD, Zee B, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst. 2002; 94: 1614-1619.
15. Lo YMD, Chan ATC, Chan LYS, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res. 2000; 60: 6878-6881.
16. Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med. 2004; 350: 2461-2470.
17. Lin JC, Wang WY, Liang WM, et al. Long-term prognostic effects of plasma Epstein-Barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2007; 68: 1342-1348.
18. Shotelersuk K, Khorprasert C, Sakdikul S, Pornthanakasem W, Voravud N, Mutirangura A,. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res. 2000; 6: 1046-1051.
19. Wong LP, Lai KT, Tsui E, Kwong KH, Tsang RH, Ma ES,. Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)? Int J Cancer. 2005; 117: 515-516.
20. Chien YC, Chen JY, Liu MY, et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med. 2001; 345: 1877-1882.
21. Chan KCA, Zhang J, Chan ATC, et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res. 2003; 63: 2028-2032.
22. Tang JW, Rohwader E, Chu IM, et al. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma. J Clin Virol. 2007; 40: 284-288.
23. Chan KCA, Chan AT, Leung SF, et al. Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma. Clin Chem. 2005; 51: 2192-2195.
24. Ma BB, King A, Lo YMD, et al. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006; 66: 714-720.
25. King AD, Vlantis AC, Bhatia KS, et al. Primary nasopharyngeal carcinoma: diagnostic accuracy of MR imaging versus that of endoscopy and endoscopic biopsy. Radiology. 2011; 258: 531-537.
26. King AD, Vlantis AC, Tsang RK, et al. Magnetic resonance imaging for the detection of nasopharyngeal carcinoma. AJNR Am J Neuroradiol. 2006; 27: 1288-1291.